查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1349406

尼古丁替代疗法市场（产品类型：戒烟辅助设备和电子烟系统；分销管道：零售药房、医院药房和线上商店）- 全球行业分析、规模、份额、成长、趋势和预测，2023-2031 年

Nicotine Replacement Therapy Market (Product Type: Smoking Cessation Aids & Vaping System; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, & Online Stores) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

尼古丁替代疗法市场 - 报告范围

TMR 关于全球尼古丁替代疗法市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球尼古丁替代疗法的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球尼古丁替代疗法市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解尼古丁替代疗法市场。

市场概况
2023年市场价值 270 亿美元
2031 年市场价值 521 亿美元
复合年增长率 0.077%

该报告深入研究了全球尼古丁替代疗法市场的竞争格局。全球尼古丁替代疗法市场的主要参与者已经确定，并且每个参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球尼古丁替代疗法市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 主要国家的监理格局分析
  • 供应/价值链分析
  • 最新动态/最新产品发布/关键策略
  • 主要地区吸烟成瘾盛行率/发生率
  • 按地区划分接受 NRT 治疗的个体的盛行率/发生率
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2017-2031
    • 戒烟辅助工具
      • 尼古丁吸入器
      • 尼古丁口香糖
      • 尼古丁含片
      • 尼古丁贴片
      • 其他的
    • 电子烟系统
      • 电子烟
      • 加热不燃烧烟草製品
  • 市场吸引力分析：按产品类型

第 7 章：全球市场分析与预测：按分销管道

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：2017-2031年按通路
    • 零售药局
    • 医院药房
    • 网上商店
  • 市场吸引力分析：按分销管道

第 8 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 9 章：北美市场分析与预测

第 10 章：欧洲市场分析与预测

第 11 章：亚太市场分析与预测

第 12 章：拉丁美洲市场分析与预测

第 13 章：中东和非洲市场分析与预测

第 14 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分，2022 年
  • 公司简介
    • Haleon Group of Companies
    • Pfizer, Inc.
    • McNeil AB (Johnson & Johnson)
    • SAABI NZ PTY Limited
    • PL Developments
    • Cipla Limited
    • BAT plc
    • JT International SA
    • Imperial Brands plc
    • Sparsha Pharma International Pvt. Ltd.
    • Pierre Fabre SA
    • Lucy Goods
    • Rubicon Research Pvt. Ltd.
    • JUUL Labs, Inc.
    • Fontem Holdings 4 BV
    • Philip Morris International, Inc.
    • Perrigo Company plc
Product Code: TMRGL54747

Nicotine Replacement Therapy Market - Scope of Report

TMR's report on the global nicotine replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nicotine replacement therapy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nicotine replacement therapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nicotine replacement therapy market.

Market Snapshot
Market Value in 2023US$ 27 Bn
Market Value in 2031US$ 52.1 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nicotine replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nicotine replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nicotine replacement therapy market.

The report delves into the competitive landscape of the global nicotine replacement therapy market. Key players operating in the global nicotine replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nicotine replacement therapy market profiled in this report.

Key Questions Answered in Global Nicotine Replacement Therapy Market Report:

  • What is the sales/revenue generated by nicotine replacement therapy across all regions during the forecast period?
  • What are the opportunities in the global nicotine replacement therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nicotine Replacement Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global nicotine replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nicotine replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nicotine replacement therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nicotine Replacement Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nicotine Replacement Therapy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory landscape analysis by key countries
  • 5.2. Supply/Value chain analysis
  • 5.3. Recent Developments/Latest product launches/Key strategies
  • 5.4. Prevalence/Incidence of Smoking Addiction by key regions
  • 5.5. Prevalence/Incidence of Individuals Undergoing NRT Therapy by Region
  • 5.6. COVID-19 Pandemic Impact on Industry

6. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Smoking Cessation Aids
      • 6.3.1.1. Nicotine Inhalers
      • 6.3.1.2. Nicotine Gums
      • 6.3.1.3. Nicotine Lozenges
      • 6.3.1.4. Nicotine Patches
      • 6.3.1.5. Others
    • 6.3.2. Vaping System
      • 6.3.2.1. E-cigarettes
      • 6.3.2.2. Heat-not-burn Tobacco Products
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Retail Pharmacies
    • 7.3.2. Hospital Pharmacies
    • 7.3.3. Online Stores
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Nicotine Replacement Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product Type, 2017-2031
    • 9.2.1. Smoking Cessation Aids
      • 9.2.1.1. Nicotine Inhalers
      • 9.2.1.2. Nicotine Gums
      • 9.2.1.3. Nicotine Lozenges
      • 9.2.1.4. Nicotine Patches
      • 9.2.1.5. Others
    • 9.2.2. Vaping System
      • 9.2.2.1. E-cigarettes
      • 9.2.2.2. Heat-not-burn Tobacco Products
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Hospital Pharmacies
    • 9.3.3. Online Stores
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Nicotine Replacement Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Smoking Cessation Aids
      • 10.2.1.1. Nicotine Inhalers
      • 10.2.1.2. Nicotine Gums
      • 10.2.1.3. Nicotine Lozenges
      • 10.2.1.4. Nicotine Patches
      • 10.2.1.5. Others
    • 10.2.2. Vaping System
      • 10.2.2.1. E-cigarettes
      • 10.2.2.2. Heat-not-burn Tobacco Products
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Retail Pharmacies
    • 10.3.2. Hospital Pharmacies
    • 10.3.3. Online Stores
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Smoking Cessation Aids
      • 11.2.1.1. Nicotine Inhalers
      • 11.2.1.2. Nicotine Gums
      • 11.2.1.3. Nicotine Lozenges
      • 11.2.1.4. Nicotine Patches
      • 11.2.1.5. Others
    • 11.2.2. Vaping System
      • 11.2.2.1. E-cigarettes
      • 11.2.2.2. Heat-not-burn Tobacco Products
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Retail Pharmacies
    • 11.3.2. Hospital Pharmacies
    • 11.3.3. Online Stores
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Nicotine Replacement Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Smoking Cessation Aids
      • 12.2.1.1. Nicotine Inhalers
      • 12.2.1.2. Nicotine Gums
      • 12.2.1.3. Nicotine Lozenges
      • 12.2.1.4. Nicotine Patches
      • 12.2.1.5. Others
    • 12.2.2. Vaping System
      • 12.2.2.1. E-cigarettes
      • 12.2.2.2. Heat-not-burn Tobacco Products
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Retail Pharmacies
    • 12.3.2. Hospital Pharmacies
    • 12.3.3. Online Stores
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Nicotine Replacement Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Smoking Cessation Aids
      • 13.2.1.1. Nicotine Inhalers
      • 13.2.1.2. Nicotine Gums
      • 13.2.1.3. Nicotine Lozenges
      • 13.2.1.4. Nicotine Patches
      • 13.2.1.5. Others
    • 13.2.2. Vaping System
      • 13.2.2.1. E-cigarettes
      • 13.2.2.2. Heat-not-burn Tobacco Products
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Retail Pharmacies
    • 13.3.2. Hospital Pharmacies
    • 13.3.3. Online Stores
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. Haleon Group of Companies
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Pfizer, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. McNeil AB (Johnson & Johnson)
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. SAABI NZ PTY Limited
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. PL Developments
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Cipla Limited
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. BAT plc
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. JT International SA
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Imperial Brands plc
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Sparsha Pharma International Pvt. Ltd.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Pierre Fabre S.A.
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. Financial Overview
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. Lucy Goods
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Product Portfolio
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview
    • 14.3.13. Rubicon Research Pvt. Ltd.
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. Financial Overview
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview
    • 14.3.14. JUUL Labs, Inc.
      • 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. Financial Overview
      • 14.3.14.4. SWOT Analysis
      • 14.3.14.5. Strategic Overview
    • 14.3.15. Fontem Holdings 4 B.V.
      • 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. Financial Overview
      • 14.3.15.4. SWOT Analysis
      • 14.3.15.5. Strategic Overview
    • 14.3.16. Philip Morris International, Inc.
      • 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.16.2. Product Portfolio
      • 14.3.16.3. Financial Overview
      • 14.3.16.4. SWOT Analysis
      • 14.3.16.5. Strategic Overview
    • 14.3.17. Perrigo Company plc
      • 14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.17.2. Product Portfolio
      • 14.3.17.3. Financial Overview
      • 14.3.17.4. SWOT Analysis
      • 14.3.17.5. Strategic Overview

List of Tables

  • Table 01: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2032
  • Table 03: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System, 2017-2033
  • Table 04: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 08: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System, 2017-2032
  • Table 09: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: North America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 13: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 14: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 15: Europe Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 17: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 18: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 19: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Asia Pacific Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 22: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 23: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 24: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Latin America Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Smoking Cessation Aids, 2017-2031
  • Table 28: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Vaping System
  • Table 29: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 30: Middle East & Africa Nicotine Replacement Therapy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Nicotine Replacement Therapy Market Value Share, by Product Type, 2022
  • Figure 03: Global Nicotine Replacement Therapy Market Value Share, by Distribution Channel, 2022
  • Figure 04: Global Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 05: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Smoking Cessation Aids, 2017-2031
  • Figure 06: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Vaping System, 2017-2031
  • Figure 07: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 08: Global Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 09: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 10: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 11: Global Nicotine Replacement Therapy Market Revenue (US$ Mn), by Online Stores, 2017-2031
  • Figure 12: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 13: Global Nicotine Replacement Therapy Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 14: Global Nicotine Replacement Therapy Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 15: North America Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: North America Nicotine Replacement Therapy Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 17: North America Nicotine Replacement Therapy Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 18: North America Nicotine Replacement Therapy Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 19: North America Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type 2023-2031
  • Figure 20: North America Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 21: North America Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 22: Europe Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Europe Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 26: Europe Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 27: Europe Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 28: Europe Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 29: Asia Pacific Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 31: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 32: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 33: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 34: Asia Pacific Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 35: Asia Pacific Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 36: Latin America Nicotine Replacement Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Latin America Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 38: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 39: Latin America Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 40: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 41: Latin America Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 42: Latin America Nicotine Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 43: Middle East and Africa Nicotine Replacement Therapy Market Value (US$ Mn), 2017-2031
  • Figure 44: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 47: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness by Product Type, 2023-2031
  • Figure 48: Middle East and Africa Nicotine Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 49: Middle East and Africa Nicotine Replacement Therapy Market Attractiveness, by Distribution Channel, 2023-2031
  • Figure 50: Company Share Analysis Nicotine Replacement Therapy, 2022